Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc. a pioneering leader of advanced metabolomics, announced outcome results today from two large-cohort studies evaluating the clinical utility of Quantose, the company’s blood test for prediabetes. The studies provided further evidence that the Quantose test identifies individuals at risk for type 2 diabetes earlier and more accurately than traditional risk factors alone.
Help employers find you! Check out all the jobs and post your resume.
